Pharmaceutical Market Europe - October 2021

PME October 2021 - Time for pharma to ditch its cautious approach to creativity in comms, Alzheimer’s disease and beyond, Amarin is rethinking cardiovascular risk

Related Keywords

Christos Papadopoulos ,Mike Crichton ,Tatyana Tyx ,Karim Mikhail ,Simon Lovestone ,Chris Ross , ,Disease Area Stronghold ,Rethinking Cardiovascular ,European Head Commercial Excellence ,